1. Home
  2. DRCT vs PFSA Comparison

DRCT vs PFSA Comparison

Compare DRCT & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$0.57

Market Cap

1.8M

Sector

Technology

ML Signal

HOLD

PFSA

Profusa Inc.

HOLD

Current Price

$0.86

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRCT
PFSA
Founded
2018
2009
Country
United States
United States
Employees
73
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
1.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DRCT
PFSA
Price
$0.57
$0.86
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$8.00
N/A
AVG Volume (30 Days)
79.8K
6.5M
Earning Date
05-05-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,694,000.00
N/A
Revenue This Year
$58.20
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.04
$0.05
52 Week High
$6.04
$4.22

Technical Indicators

Market Signals
Indicator
DRCT
PFSA
Relative Strength Index (RSI) 29.44 49.33
Support Level $0.34 $0.83
Resistance Level $0.61 $2.22
Average True Range (ATR) 0.09 0.18
MACD 0.00 0.06
Stochastic Oscillator 12.54 23.59

Price Performance

Historical Comparison
DRCT
PFSA

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: